Guillermo Lahera

Guillermo Lahera


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
CGCielo García-Montero
Cielo García-Montero
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
AGAna M. Gómez-Lahoz
Ana M. Gómez-Lahoz
LPLeonel Pekarek
Leonel Pekarek
ACAlejandro J. Castellanos
Alejandro J. Castellanos
Miguel A. OrtegaMiguel A. Ortega
Miguel A. Ortega
The most prevalent diseases of our time, non-communicable diseases (NCDs) (including obesity, type 2 diabetes, cardiovascular diseases and some types of cancer) are rising worldwide. All of them share the condition of an “inflammatory disorder”, with impaired immune functions frequently caused or accompanied by alterations in gut microbiota. These multifactorial maladies also have in common malnutrition related to physiopathology. In this context, diet is the greatest modulator of immune system–microbiota crosstalk, and much interest, and new challenges, are arising in the area of precision nutrition as a way towards treatment and prevention. It is a fact that the westernized diet (WD) is partly responsible for the increased prevalence of NCDs, negatively affecting both gut microbiota and the immune system. Conversely, other nutritional approaches, such as Mediterranean diet (MD), positively influence immune system and gut microbiota, and is proposed not only as a potential tool in the clinical management of different disease conditions, but also for prevention and health promotion globally. Thus, the purpose of this review is to determine the regulatory role of nutritional components of WD and MD in the gut microbiota and immune system interplay, in order to understand, and create awareness of, the influence of diet over both key components.

8 January 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Miguel A. OrtegaMiguel A. Ortega
Miguel A. Ortega
Miguel Angel Alvarez-MonMiguel Angel Alvarez-Mon
Miguel Angel Alvarez-Mon
CGCielo García-Montero
Cielo García-Montero
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
Luis G GuijarroLuis G Guijarro
Luis G Guijarro
Melchor AlvarezMelchor Alvarez
Melchor Alvarez
The gut microbiota is a complex and dynamic ecosystem essential for the proper functioning of the organism, affecting the health and disease status of the individuals. There is continuous and bidirectional communication between gut microbiota and the host, conforming to a unique entity known as “holobiont”. Among these crosstalk mechanisms, the gut microbiota synthesizes a broad spectrum of bioactive compounds or metabolites which exert pleiotropic effects on the human organism. Many of these microbial metabolites can cross the blood–brain barrier (BBB) or have significant effects on the brain, playing a key role in the so-called microbiota-gut-brain axis. An altered microbiota-gut-brain (MGB) axis is a major characteristic of many neuropsychiatric disorders, including major depressive disorder (MDD). Significative differences between gut eubiosis and dysbiosis in mental disorders like MDD with their different metabolite composition and concentrations are being discussed. In the present review, the main microbial metabolites (short-chain fatty acids -SCFAs-, bile acids, amino acids, tryptophan -trp- derivatives, and more), their signaling pathways and functions will be summarized to explain part of MDD pathophysiology. Conclusions from promising translational approaches related to microbial metabolome will be addressed in more depth to discuss their possible clinical value in the management of MDD patients.

1 March 2013 in Journal of Affective Disorders
Verified
Journal Article
Closed access
GLGuillermo Lahera
Guillermo Lahera
ABA. Benito
A. Benito
JMJ.M. Montes
J.M. Montes
AFA. Fernández-Liria
A. Fernández-Liria
COC.M. Olbert
C.M. Olbert
DPD.L. Penn
D.L. Penn

31 January 2015 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
GLGuillermo Lahera
Guillermo Lahera
SHS. Herrera
S. Herrera
MRM. Reinares
M. Reinares
ABA. Benito
A. Benito
MRM. Rullas
M. Rullas
Eduard VietaEduard Vieta
Eduard Vieta

1 December 2008 in Psychiatry Research
Verified
Journal Article
Closed access
GLGuillermo Lahera
Guillermo Lahera
JMJosé Manuel Montes
José Manuel Montes
ABAdolfo Benito
Adolfo Benito
MVMaría Valdivia
María Valdivia
EMElena Medina
Elena Medina
JSJerónimo Sáiz-Ruiz
Jerónimo Sáiz-Ruiz

28 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Miguel A. OrtegaMiguel A. Ortega
Miguel A. Ortega
ÓMÓscar Fraile Martínez
Óscar Fraile Martínez
CGCielo García-Montero
Cielo García-Montero
Miguel Angel Alvarez-MonMiguel Angel Alvarez-Mon
Miguel Angel Alvarez-Mon
GLGuillermo Lahera
Guillermo Lahera
Melchor AlvarezMelchor Alvarez
Melchor Alvarez
Major Depressive Disorder (MDD) is a growing disabling condition affecting around 280 million people worldwide. This complex entity is the result of the interplay between biological, psychological, and sociocultural factors, and compelling evidence suggests that MDD can be considered a disease that occurs as a consequence of an evolutionary mismatch and unhealthy lifestyle habits. In this context, diet is one of the core pillars of health, influencing multiple biological processes in the brain and the entire body. It seems that there is a bidirectional relationship between MDD and malnutrition, and depressed individuals often lack certain critical nutrients along with an aberrant dietary pattern. Thus, dietary interventions are one of the most promising tools to explore in the field of MDD, as there are a specific group of nutrients (i.e., omega 3, vitamins, polyphenols, and caffeine), foods (fish, nuts, seeds fruits, vegetables, coffee/tea, and fermented products) or dietary supplements (such as S-adenosylmethionine, acetyl carnitine, creatine, amino acids, etc.), which are being currently studied. Likewise, the entire nutritional context and the dietary pattern seem to be another potential area of study, and some strategies such as the Mediterranean diet have demonstrated some relevant benefits in patients with MDD; although, further efforts are still needed. In the present work, we will explore the state-of-the-art diet in the prevention and clinical support of MDD, focusing on the biological properties of its main nutrients, foods, and dietary patterns and their possible implications for these patients.